Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V Twelve-year mortality rates and prognostic factors: COMS report No 28 Arch Ophthalmol Chic Ill 1960; 124(12): 1684-93.1960.
Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, et al. Management of invasive squamous cell carcinomas of the conjunctiva Treatment of invasive conjunctival carcinoma. Am J Ophthalmol 2018.
Shields DJA, Shields DCL. Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook. In: LWW. 3rd ed. Philadelphia 2015.
Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, et al. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol . 2019. [Epub ahead of print]
Cook JR, Isaacson PG, Chott A, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)WHO classification of tumours of haematopoietic and lymphoid tissues Revised 4th. Lyon: IARC 2017; pp. 259-62.
Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers 2015; 1: 15021.
Gascoyne RD, Campo E, Jaffe ES, et al. Diffuse large B-cell lymphoma, NOSWHO classification of tumours of haematopoietic and lymphoid tissues Revised 4th. Lyon: IARC 2017; pp. 291-7.
Kluin PM, Harris NL, Stein H, et al. High-grade B-cell lymphomaWHO classification of tumours of haematopoietic and lymphoid tissues Revised 4th. Lyon: IARC 2017; pp. 335-41.
Kluin PM, Deckert M, Ferry JA. Primary diffuse large B-cell lymphoma of the CNSWHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition. Lyon: IARC 2017; pp. 300-2.
Choquet S, Houillier C, Bijou F, Houot R, Boyle E, Gressin R, et al. Ibrutinib monotherapy in relapse or refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the interim analysis of the iLOC phase II study from the lysa and the french LOC network. Blood 2016; 128(22): 784-4.
Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med 2018; 378(15): 1396-407.
Berry D, Seider M, Stinnett S, Mruthyunjaya P, Schefler AC. Ocular oncology study consortium Relationship of clinical features and baseline tumor size with gene expression profile status in uveal melanoma: A multi-institutional study. Retina Phila Pa 2018.
Amaro A, Mirisola V, Angelini G, Musso A, Tosetti F, Esposito AI, et al. Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. Eur J Cancer Oxf Engl 49 (15): 3353-65.1990.
Jaffe ES, Harris NL, Siebert R. Paediatric-type follicular lymphomaWHO classification of tumours of haematopoietic and lymphoid tissues Revised 4th IARC Lyon. 2017; pp. 278-9.
Ladanyi M, Fletcher JA, Dal Cin P. Cytogenetic and Molecular Genetic Pathology of Soft Tissue Tumors. In: Enzinger and Weiss’s soft tissue tumors 6th ed Saunders/Elsevier 6th ed Philadelphia, PA. 2014; pp. 76-109.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, Eds. WHO classification of tumours of soft tissueWHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC 2013; pp. 9-11.